Search
Patexia Research
Case number 2017-1010

Amgen Inc. v. Apotex Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 AMGEN INC. v. APOTEX INC. [OPINION] [nonprecedential] (0)
Dec 20, 2017 57 Mandate issued to the United States District Court for the Southern District of Florida. Service as of this date by Clerk of Court. [484211] [JAB] [Entered: 12/20/2017 12:33 PM] (1)
Nov 13, 2017 56 OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Nonprecedential Opinion). (For the Court: Lourie,Circuit Judge; O'Malley,Circuit Judge and Taranto,Circuit Judge). [474616] [SJ] [Entered: 11/13/2017 09:08 AM] (19)
Oct 3, 2017 55 Submitted after ORAL ARGUMENT by Nicholas P. Groombridge for Amgen Manufacturing Limited and Amgen Inc. and Barry P. Golob for Apotex Inc. and Apotex Corp. Panel: Judge: Lourie , Judge: O'Malley , Judge: Taranto. [465362] [JAB] [Entered: 10/04/2017 08:15 AM] (0)
Sep 12, 2017 54 Response to oral argument order from the Appellees Apotex Corp. and Apotex Inc.. designating Barry P. Golob as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [460476] [Barry Golob] [Entered: 09/12/2017 03:55 PM] (0)
Sep 11, 2017 53 Response to oral argument order from the Appellants Amgen Inc. and Amgen Manufacturing Limited. designating Nicholas Groombridge as arguing attorney. Designated time for argument: 13 minutes. Designated time for rebuttal: 2 minutes. Service of other counsel by Notice of Docket Activity from this entry. [460106] [Nicholas Groombridge] [Entered: 09/11/2017 12:29 PM] (0)
Aug 21, 2017 52 NOTICE OF CALENDARING. Panel: 1710B. Case scheduled Oct 03, 2017 2:00 p.m. at the Benjamin N. Cardozo School of Law (55 5th Avenue, New York, NY 10003), Jacob Burns Moot Courtroom. Response to oral argument order due: 09/15/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [455488] [JAB] [Entered: 08/21/2017 03:40 PM] (0)
Aug 9, 2017 51 Notice from Appellees Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (October 5-6, 2017). Service: 08/09/2017 by email. [452522] [Barry Golob] [Entered: 08/09/2017 09:53 AM] (2)
Jul 12, 2017 50 Notice from Appellants Amgen Inc. and Amgen Manufacturing Limited regarding conflicts with oral argument (Amgen respectfully requests that oral argument not be set for the September 5-8 court session. Amgen is available during the October 2-6 court session.). Service: 07/12/2017 by email. [445838] [Nicholas Groombridge] [Entered: 07/12/2017 11:29 AM] (2)
Jun 30, 2017 49 **TEXT ONLY** ORDER granting motion to withdraw attorney Ana J. Friedman [48] filed by Appellants Amgen Manufacturing Limited and Amgen Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [443488] [JCA] [Entered: 06/30/2017 01:30 PM] (0)
Jun 30, 2017 48 MOTION of Appellants Amgen Inc. and Amgen Manufacturing Limited to withdraw counsel Ana J. Friedman. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/30/2017 by email. [443461] [Nicholas Groombridge] [Entered: 06/30/2017 12:52 PM] (5)
Apr 28, 2017 47 Notice from Appellants Amgen Inc. and Amgen Manufacturing Limited regarding conflicts with oral argument (Oral argument not be set for July 14, August 7-9, and August 11). Service: 04/28/2017 by email. [427834] [Nicholas Groombridge] [Entered: 04/28/2017 01:50 PM] (2)
Feb 15, 2017 46 Notice from Appellants Amgen Inc. and Amgen Manufacturing Limited regarding conflicts with oral argument (Oral argument not be set for the following dates: April 3-7, April 10, May 1-4, and June 5-9. Oral arguments in Nos. 16-2179 and 17-1010 not be scheduled on the same day.). Service: 02/15/2017 by email. [407952] [Nicholas Groombridge] [Entered: 02/15/2017 05:05 PM] (2)
Feb 15, 2017 45 Notice from Appellees Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (May 1- 5, 2017 and May 8, 2017). Service: 02/15/2017 by email. [407930] [Barry Golob] [Entered: 02/15/2017 04:28 PM] (2)
Feb 14, 2017 44 6 paper copies of the Joint Appendix (Vol. I-III) [42] received from Appellants Amgen Inc. and Amgen Manufacturing Limited. [407346] [KW] [Entered: 02/14/2017 02:40 PM] (0)
Feb 8, 2017 43 Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks (April 2017, May 2017, June 2017), or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 02/15/2017. [405541] [JCA] [Entered: 02/08/2017 10:23 AM] (0)
Feb 7, 2017 42 APPENDIX FILED for Amgen Inc. and Amgen Manufacturing Limited [41], [40], [39]. Number of Pages: 1391. Service: 02/07/2017 by email. The paper copies of the brief should be received by the court on or before 02/15/2017. [405537] [JCA] [Entered: 02/08/2017 10:22 AM] (1391)
Feb 7, 2017 41 TENDERED from Appellants Amgen Inc., Amgen Manufacturing Limited and Appellees Apotex Corp. and Apotex Inc.. Title: JOINT APPENDIX. Service: 02/07/2017 by email. [405426] [Nicholas Groombridge] [Entered: 02/07/2017 04:46 PM] (360)
Feb 7, 2017 40 TENDERED from Appellants Amgen Inc., Amgen Manufacturing Limited and Appellees Apotex Corp. and Apotex Inc.. Title: JOINT APPENDIX. Service: 02/07/2017 by email. [405424] [Nicholas Groombridge] [Entered: 02/07/2017 04:45 PM] (537)
Feb 7, 2017 39 TENDERED from Appellants Amgen Inc., Amgen Manufacturing Limited and Appellees Apotex Corp. and Apotex Inc.. Title: JOINT APPENDIX. Service: 02/07/2017 by email. [405422] [Nicholas Groombridge] [Entered: 02/07/2017 04:44 PM] (494)
Feb 6, 2017 38 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Amgen Inc., Amgen Manufacturing Limited and Appellees Apotex Corp. and Apotex Inc.. Service: 02/06/2017 by email. [404810] [Nicholas Groombridge] [Entered: 02/06/2017 11:08 AM] (3)
Feb 2, 2017 37 6 paper copies of the Reply Brief [36] received from Appellants Amgen Inc. and Amgen Manufacturing Limited. [404206] [KW] [Entered: 02/02/2017 02:02 PM] (0)
Jan 31, 2017 36 REPLY BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing Limited [35]. Number of Pages: 32. Service: 01/31/2017 by email. The paper copies of the brief should be received by the court on or before 02/08/2017. Appendix is due 02/07/2017. [403629] [JCA] [Entered: 02/01/2017 09:08 AM] (41)
Jan 31, 2017 35 TENDERED from Appellants Amgen Inc. and Amgen Manufacturing Limited. Title: REPLY BRIEF. Service: 01/31/2017 by email. [403575] [Nicholas Groombridge] [Entered: 01/31/2017 06:54 PM] (41)
Jan 24, 2017 34 Statement of Compliance with Fed. Cir. R. 33 for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 01/24/2017 by email. [401367] [Nicholas Groombridge] [Entered: 01/24/2017 01:01 PM] (3)
Jan 19, 2017 33 6 paper copies of the Response Brief [32] received from Appellees Apotex Corp. and Apotex Inc. [400358] [KW] [Entered: 01/19/2017 11:40 AM] (0)
Jan 17, 2017 32 BRIEF FILED for Appellees Apotex Corp. and Apotex Inc. [31]. Number of Pages: 61. Service: 01/17/2017 by email. The paper copies of the brief should be received by the court on or before 01/26/2017. Appellants Amgen Inc. and Amgen Manufacturing Limited reply brief is due 01/31/2017. [399791] [JCA] [Entered: 01/18/2017 09:32 AM] (74)
Jan 17, 2017 31 TENDERED from Appellees Apotex Corp. and Apotex Inc.. Title: RESPONSE BRIEF. Service: 01/17/2017 by email. [399697] [Barry Golob] [Entered: 01/17/2017 04:59 PM] (74)
Dec 15, 2016 30 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [391509] [JCA] [Entered: 12/15/2016 03:29 PM] (0)
Dec 7, 2016 29 6 paper copies of the Opening Brief [28] received from Appellants Amgen Inc. and Amgen Manufacturing Limited. [389093] [KW] [Entered: 12/07/2016 02:37 PM] (0)
Dec 5, 2016 28 BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing Limited [27]. Number of Pages: 67. Service: 12/05/2016 by email. The paper copies of the brief should be received by the court on or before 12/12/2016. Appellees Apotex Corp. and Apotex Inc. brief is due 01/17/2017. [388533] [JCA] [Entered: 12/06/2016 11:16 AM] (145)
Dec 5, 2016 27 TENDERED from Appellants Amgen Inc. and Amgen Manufacturing Limited. Title: OPENING BRIEF. Service: 12/05/2016 by email. [388400] [Nicholas Groombridge] [Entered: 12/05/2016 11:00 PM] (145)
Oct 18, 2016 26 Docketing Statement for the Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/18/2016 by email. [375610] [Nicholas Groombridge] [Entered: 10/18/2016 06:15 PM] (4)
Oct 18, 2016 25 Amended Docketing Statement for the Appellees Apotex Corp. and Apotex Inc.. Service: 10/18/2016 by email. [375281] [Barry Golob] [Entered: 10/18/2016 11:41 AM] (3)
Oct 17, 2016 24 Transcript Purchase Order Form for the Appellants Amgen Inc. and Amgen Manufacturing Limited indicating that a transcript is already on file. Service: 10/17/2016 by email. [375055] [Jason Sternberg] [Entered: 10/17/2016 04:30 PM] (2)
Oct 17, 2016 23 Entry of appearance for Aaron S. Lukas as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/17/2016 by email. [374835] [Barry Golob] [Entered: 10/17/2016 12:45 PM] (2)
Oct 17, 2016 22 Entry of appearance for William Blake Coblentz as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/17/2016 by email. [374832] [Barry Golob] [Entered: 10/17/2016 12:43 PM] (2)
Oct 17, 2016 21 Entry of appearance for Kerry B. McTigue as of counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/17/2016 by email. [374831] [Barry Golob] [Entered: 10/17/2016 12:41 PM] (2)
Oct 17, 2016 20 Docketing Statement for the Appellees Apotex Corp. and Apotex Inc.. Service: 10/17/2016 by email. [374829] [Barry Golob] [Entered: 10/17/2016 12:36 PM] (3)
Oct 17, 2016 19 Certificate of Interest for the Appellees Apotex Corp. and Apotex Inc.. Service: 10/17/2016 by email. [374822] [Barry Golob] [Entered: 10/17/2016 12:30 PM] (5)
Oct 17, 2016 18 Entry of appearance for Barry P. Golob as principal counsel for Appellees Apotex Corp. and Apotex Inc.. Service: 10/17/2016 by email. [374806] [Barry Golob] [Entered: 10/17/2016 12:13 PM] (2)
Oct 12, 2016 17 Entry of appearance for Allen P. Pegg as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/12/2016 by email. [373492] [Allen Pegg] [Entered: 10/12/2016 12:08 PM] (2)
Oct 12, 2016 16 Entry of appearance for Jason D. Sternberg as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/12/2016 by email. [373421] [Jason Sternberg] [Entered: 10/12/2016 10:42 AM] (2)
Oct 12, 2016 15 Entry of appearance for John F. O'Sullivan as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/12/2016 by email. [373416] [John O'Sullivan] [Entered: 10/12/2016 10:36 AM] (2)
Oct 7, 2016 14 Certificate of Interest for the Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372831] [Nicholas Groombridge] [Entered: 10/07/2016 05:32 PM] (2)
Oct 7, 2016 13 Entry of appearance for Wendy A. Whiteford as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372830] [Nicholas Groombridge] [Entered: 10/07/2016 05:31 PM] (2)
Oct 7, 2016 12 Entry of appearance for Kimberlin L. Morley as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372829] [Nicholas Groombridge] [Entered: 10/07/2016 05:28 PM] (2)
Oct 7, 2016 11 Entry of appearance for Lois M. Kwasigroch as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372828] [Nicholas Groombridge] [Entered: 10/07/2016 05:26 PM] (2)
Oct 7, 2016 10 Entry of appearance for Stephen A. Maniscalco as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372827] [Nicholas Groombridge] [Entered: 10/07/2016 05:24 PM] (2)
Oct 7, 2016 9 Entry of appearance for Arielle K. Linsey as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372825] [Nicholas Groombridge] [Entered: 10/07/2016 05:22 PM] (2)
Oct 7, 2016 8 Entry of appearance for Ana J. Friedman as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372824] [Nicholas Groombridge] [Entered: 10/07/2016 05:20 PM] (2)
Oct 7, 2016 7 Entry of appearance for Peter Sandel as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372823] [Nicholas Groombridge] [Entered: 10/07/2016 05:17 PM] (2)
Oct 7, 2016 6 Entry of appearance for Jennifer Gordon as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372822] [Nicholas Groombridge] [Entered: 10/07/2016 05:15 PM] (2)
Oct 7, 2016 5 Entry of appearance for Jennifer H. Wu as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372820] [Nicholas Groombridge] [Entered: 10/07/2016 05:13 PM] (2)
Oct 7, 2016 4 Entry of appearance for Eric A. Stone as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372818] [Nicholas Groombridge] [Entered: 10/07/2016 05:11 PM] (2)
Oct 7, 2016 3 Entry of appearance for Catherine Nyarady as of counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372817] [Nicholas Groombridge] [Entered: 10/07/2016 05:08 PM] (2)
Oct 7, 2016 2 Entry of appearance for Nicholas P. Groombridge as principal counsel for Appellants Amgen Inc. and Amgen Manufacturing Limited. Service: 10/07/2016 by email. [372815] [Nicholas Groombridge] [Entered: 10/07/2016 05:05 PM] (2)
Oct 4, 2016 1 Appeal docketed. Received: 10/04/2016. [371302]Entry of Appearance due 10/18/2016. Certificate of Interest is due on 10/18/2016. Docketing Statement due 10/18/2016. Appellant/Petitioner's brief is due 12/05/2016. [JCA] [Entered: 10/04/2016 12:23 PM] (110)
Menu